共 230 条
[1]
Avila MA(2006)New therapies for hepatocellular carcinoma Oncogene 25 3866-2576
[2]
Berasain C(2007)Hepatocellular carcinoma: epidemiology and molecular carcinogenesis Gastroenterology 132 2557-15
[3]
Sangro B(2009)An overview of hepatocellular carcinoma study by omics-based methods Acta Biochim Biophys Sin 41 1-6051
[4]
Prieto J(2011)Upregulation of Rac GTPase-activating protein 1 is significantly associated with the early recurrence of human hepatocellular carcinoma Clin Cancer Res 17 6040-1236
[5]
El-Serag HB(2005)Management of hepatocellular carcinoma Hepatology 42 1208-1426
[6]
Rudolph KL(2011)Targeted therapies for hepatocellular carcinoma Gastroenterology 140 1410-18819
[7]
Pei Y(2015)Correlation of increased MALAT1 expression with pathological features and prognosis in cancer patients: a meta-analysis Genet Mol Res 14 18808-1024
[8]
Zhang T(2016)Prognostic significance of long non-coding RNA MALAT-1 in various human carcinomas: a meta-analysis Genet Mol Res 44 1012-1816
[9]
Renault V(2006)Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas Hepatology 7 5769-469
[10]
Zhang X(2016)A MALAT1/HIF-2α feedback loop contributes to arsenite carcinogenesis Oncotarget 29 1810-1248